H.C. Wainwright lowered the firm’s price target on Arvinas (ARVN) to $81 from $87 and keeps a Buy rating on the shares. Given the company’s ...
H.C. Wainwright lowered the firm’s price target on Sage Therapeutics (SAGE) to $12 from $14 and keeps a Neutral rating on the shares. The ...
Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Viking Therapeutics in a research note issued on Thursday, February 6th. HC Wainwright analyst J. Pantginis expects that ...
H.C. Wainwright adjusted its price target for Largo Resources Ltd. (NASDAQ:LGO) to $3.70, down from the previous $4.20, while maintaining a "Buy" rating on the stock. The firm's decision follows Largo ...
D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at ...
1d
Hosted on MSNHC Wainwright & Co. Downgrades Pliant Therapeutics (PLRX)Fintel reports that on February 10, 2025, HC Wainwright & Co. downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX ...
Rufus Wainwright is a difficult artist to categorize at the best of times. The Canadian-American musician has recorded pop songs, folk music, operas and stage musicals, but his latest album ...
Rufus Wainwright will perform at Cure Addiction Now’s inaugural fundraising gala in Los Angeles. CAN was founded by Nancy Davis and her late son Jason Davis to support innovative treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results